EMPLICITI (E.R. Squibb & Sons, L.L.C.)
Welcome to the PulseAid listing for the EMPLICITI drug offered from E.R. Squibb & Sons, L.L.C.. This SLAMF7-directed Immunostimulatory Antibody [EPC],SLAMF7-directed Antibody Interactions [MoA],Antibodies, Monoclonal [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | E.R. Squibb & Sons, L.L.C. |
| NON-PROPRIETARY NAME: | elotuzumab |
| SUBSTANCE NAME: | ELOTUZUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | SLAMF7-directed Immunostimulatory Antibody [EPC],SLAMF7-directed Antibody Interactions [MoA],Antibodies, Monoclonal [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2015-11-30 |
| END MARKETING DATE: | 0000-00-00 |
EMPLICITI HUMAN PRESCRIPTION DRUG Details:
| Item Description | EMPLICITI from E.R. Squibb & Sons, L.L.C. |
| LABELER NAME: | E.R. Squibb & Sons, L.L.C. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(mg/1) |
| START MARKETING DATE: | 2015-11-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0003-2291_ae608a81-e5f5-4f26-a061-47820341156e |
| PRODUCT NDC: | 0003-2291 |
| APPLICATION NUMBER: | BLA761035 |
Other ELOTUZUMAB Pharmaceutical Manufacturers / Labelers:
